C12N 2710/16022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2710/16022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 61 US grants and 66 published applications in this corpus.
Search patents in C12N- Granted patents
- 61
- Published applications
- 66
- Assignees
- 53
- Inventors
- 155
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 2 |
| 2003 | 1 | 2 |
| 2004 | 0 | 4 |
| 2005 | 3 | 3 |
| 2006 | 3 | 1 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 3 | 4 |
| 2010 | 0 | 3 |
| 2011 | 2 | 1 |
| 2012 | 2 | 2 |
| 2013 | 1 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 1 |
| 2017 | 0 | 3 |
| 2018 | 1 | 2 |
| 2019 | 4 | 5 |
| 2020 | 2 | 2 |
| 2021 | 0 | 3 |
| 2022 | 3 | 2 |
| 2023 | 3 | 8 |
| 2024 | 0 | 1 |
| 2025 | 5 | 6 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vaccines for treating SARS infections in cancer patients6 Jan 2026US 12,516,296 B2City of Hope
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- Chimeric antigen receptor constructs and their use in CAR-T cells25 Nov 2025US 12,479,890 B2The University of North Carolina at Chapel Hill
- Universal mammalian influenza vaccine26 Aug 2025US 12,397,050 B2Iowa State University Research Foundation, Inc.
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof12 Aug 2025US 12,385,068 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant marek's disease virus and uses thereof2 Jul 2026US 2026/0183386 A1Ceva Sante Animale
- Chimeric invasin system5 Mar 2026US 2026/0062730 A1SiVEC Biotechnologies LLC
- Modified Herpes Simplex Virus Type 16 Nov 2025US 2025/0340903 A1Eg 427
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Compositions and methods for reducing cell therapy immunogenicity23 Oct 2025US 2025/0325585 A1The General Hospital Corporation
Most cited
By later US patents
- Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus16US 6,033,670 AMerial Limited · 2000
- Viral nucleotide sequences12US 5,906,821 ARhone Merieux · 1999
- GPCR with improved cell surface expression11US 9,499,584 B2Canvax Biotech S.L · 2016
- Recombinant infectious laryngotracheitis virus10US 5,279,965 A1994
- DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis8US 5,925,733 AUniversity of Washington · 1999